We are live on ! Find out more
AVDL

Avadel Pharmaceuticals
AVDL

Delisted

AVDL was delisted on the 11th of February, 2026.

Back to rankings

87 hedge funds and large institutions have $623M invested in Avadel Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 40 increasing their positions, 15 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

216% more call options, than puts

Call options by funds: $3.88M | Put options by funds: $1.23M

167% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 15

100% more funds holding in top 10

Funds holding in top 10: 4 → 8 (+4)

20% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 15

18% more capital invested

Capital invested by funds: $527M → $623M (+$96M)

4% more funds holding

Funds holding: 84 → 87 (+3)

Holders
87
Holders Change
+3
Holders Change %
+3.57%
% of All Funds
2.34%
Holding in Top 10
8
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+100%
% of All Funds
0.22%
New
18
Increased
40
Reduced
15
Closed
15
Calls
$3.88M
Puts
$1.23M
Net Calls
+$2.65M
Net Calls Change
+$2.57M

Top Buyers

Rank Fund Capital Flow
1
PCM
Portolan Capital Management
Massachusetts
+$16.1M
2
JHIU
Janus Henderson Investors US
Colorado
+$10.8M
3
Bank of New York Mellon
Bank of New York Mellon
New York
+$9.93M
4
Deutsche Bank
Deutsche Bank
Germany
+$9.13M
5
CPIM
Columbia Partners Investment Management
Virginia
+$7.43M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$32.2M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$20.3M
3
SCM
Sarissa Capital Management
Connecticut
-$15.7M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$10.7M
5
RSCM
Rock Springs Capital Management
Maryland
-$6.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
LTFS
76
Ladenburg Thalmann Financial Services
Florida
$35K +$9.41K +525 +47%
KFA
77
Kelleher Financial Advisors
New York
$31K – – –
SSG
78
Summit Securities Group
New York
$13K +$10.8K +600 New
WA
79
WFG Advisors
Texas
$12K – – –
WC
80
Whitnell & Co
Illinois
$11K – – –
TRCT
81
Tower Research Capital (TRC)
New York
$9K +$7.91K +441 New
BRWM
82
B. Riley Wealth Management
Tennessee
$7K – – –
MTIP
83
Magee Thomson Investment Partners
California
$6K – – –
PNC Financial Services Group
84
PNC Financial Services Group
Pennsylvania
$3K +$2.64K +147 New
MAA
85
Managed Account Advisors
New Jersey
$1K +$843 +47 New
T. Rowe Price Associates
86
T. Rowe Price Associates
Maryland
– -$20.3M -1,131,500 Closed
SCM
87
Sarissa Capital Management
Connecticut
– -$15.7M -875,000 Closed
Point72 Asset Management
88
Point72 Asset Management
Connecticut
– -$6.4M -355,800 Closed
SAM
89
Senzar Asset Management
New York
– -$4.05M -225,351 Closed
IHM
90
Iguana Healthcare Management
New York
– -$2.24M -125,000 Closed
DCM
91
Driehaus Capital Management
Illinois
– -$2.12M -118,042 Closed
AA
92
AQR Arbitrage
Connecticut
– -$1.5M -83,300 Closed
TD Asset Management
93
TD Asset Management
Ontario, Canada
– -$939K -52,200 Closed
OAM
94
Oxford Asset Management
United Kingdom
– -$709K -39,413 Closed
QSS
95
Quantitative Systematic Strategies
Florida
– -$400K -22,198 Closed
Citadel Advisors
96
Citadel Advisors
Florida
– -$321K -17,865 Closed
Group One Trading
97
Group One Trading
Illinois
– -$301K -16,773 Closed
CSS
98
Cubist Systematic Strategies
Connecticut
– -$276K -15,350 Closed
Creative Planning
99
Creative Planning
Kansas
– -$99K -5,500 Closed
Northern Trust
100
Northern Trust
Illinois
– -$73K -4,050 Closed
1 2 3
4
5

AVDL Hedge Fund Activity: Q2 2015 in Review

87 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Avadel Pharmaceuticals (AVDL) for Q2 2015, worth a combined $623M — up 18% from $527M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new AVDL positions and 15 closed out — a net gain of 3 holders — while 40 added to existing stakes and 15 trimmed.

The largest buyer was Portolan Capital Management, opening a new position worth an estimated $16.1M. The largest seller was Millennium Management, cutting an estimated $32.2M.

  • 87 institutional investors held Avadel Pharmaceuticals (AVDL) as of Q2 2015, up from 84 in Q1 2015.
  • Funds reported $623M of Avadel Pharmaceuticals stock for Q2 2015, up 18% quarter-over-quarter.
  • 18 funds opened new Avadel Pharmaceuticals positions in Q2 2015 and 15 closed out, a net change of +3 holders.
  • The largest Avadel Pharmaceuticals buyer in Q2 2015 was Portolan Capital Management, an estimated $16.1M added.
  • The largest Avadel Pharmaceuticals seller in Q2 2015 was Millennium Management, an estimated $32.2M sold.

Based on aggregated 13F filings for Q2 2015.